01 1Laurus Labs
01 1EMPAGLIFLOZIN
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2018-08-02
Pay. Date : 2018-06-11
DMF Number : 32881
Submission : 2018-06-26
Status : Active
Type : II
20
Laurus Labs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is EMPAGLIFLOZIN, with a corresponding US DMF Number 32881.
Remarkably, this DMF maintains an Active status since its submission on June 26, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 02, 2018, and payment made on June 11, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II
